Project ECHO: telementoring to educate and support prescribing of HIV pre-exposure prophylaxis by community medical providers
Brian R. Wood A B D , Maren S. Mann C , Natalia Martinez-Paz B , Kenton T. Unruh B , Mary Annese B , David H. Spach A B , John D. Scott A and Joanne D. Stekler A BA University of Washington Division of Allergy and Infectious Diseases, 1959 NE Pacific Street, Seattle, WA 98195, USA.
B Mountain West AIDS Education and Training Center (MW AETC), 325 9th Avenue, Seattle, WA 98104, USA.
C University of Washington School of Nursing, 1959 NE Pacific Street, Seattle, WA 98195, USA.
D Corresponding author. Email: bwood2@uw.edu
Sexual Health 15(6) 601-605 https://doi.org/10.1071/SH18062
Submitted: 31 March 2018 Accepted: 30 August 2018 Published: 15 October 2018
Abstract
Background: Pre-exposure prophylaxis (PrEP) is an effective tool to prevent HIV infection for at-risk individuals, but access requires medical providers to be aware of and comfortable with prescribing PrEP. Project ECHO (Extension for Community Healthcare Outcomes) was started to support hepatitis C virus treatment in rural New Mexico, but has since expanded to train health practitioners to treat other medical conditions in other locations. Methods: In 2012, a Project ECHO telehealth program was launched to mentor community HIV practitioners in our region. In July 2015, quarterly PrEP didactics and monthly PrEP case discussions were incorporated into this program. The result was a pilot PrEP telementoring intervention. An initial nine-question survey assessed baseline community practitioner knowledge and attitudes towards PrEP, and a follow-up 16-item survey 2 years later assessed the effect of Project ECHO on PrEP knowledge, concerns and prescribing practices. Results: Twenty-four and 45 medical providers completed the baseline and follow-up surveys respectively. In follow-up, providers reported that Project ECHO participation helped them stay current on PrEP guidelines, improved knowledge, increased likelihood to prescribe PrEP and addressed most concerns about prescribing PrEP. One exception was continued concerns about cost and insurance access, which were addressed by adjusting the didactic curriculum. Many participants reported that the Project ECHO pilot PrEP telementoring intervention assisted them in disseminating PrEP knowledge to other medical providers in their region. Conclusions: It is feasible to incorporate PrEP training into Project ECHO distance telementoring programs as a tool to educate community practitioners and support PrEP prescribing.
Additional keywords: Medical education, telehealth.
References
[1] Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kakia A, Odoyo J, Mucunguzi A, et al., for the Partners PrEP Study Team. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012; 367 399–410.| Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.Crossref | GoogleScholarGoogle Scholar |
[2] Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker L-G, Mayer KH, Kallás EG, Amico KR, et al., for the iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363 2587–99.
| Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.Crossref | GoogleScholarGoogle Scholar |
[3] Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, Henderson FL, Pathak SR, Soud FA, Chillag KL, Mutanhaurwa R, Chirwa LI, Kasonde M, Abebe D, Buliva E, Gvetadze RJ, Johnson S, Sukalac T, Thomas VT, Hart C, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 2012; 367 423–34.
| Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.Crossref | GoogleScholarGoogle Scholar |
[4] McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, Sullivan AK, Clarke A, Reeves I, Schembri G, Mackie N, Bowman C, Lacey CJ, Apea V, Brady M, Fox J, Taylor S, Antonucci S, Koo SH, Rooney J, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomized trial. Lancet 2016; 387 53–60.
| Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomized trial.Crossref | GoogleScholarGoogle Scholar |
[5] Turner L, Roepke A, Wardell E, Teitelman AM. Do You PrEP? A review of primary care provider knowledge of PrEP and attitudes on prescribing PrEP. J Assoc Nurses AIDS Care 2018; 29 83–92.
| Do You PrEP? A review of primary care provider knowledge of PrEP and attitudes on prescribing PrEP.Crossref | GoogleScholarGoogle Scholar |
[6] Blackstock OJ, Moore BA, Berkenblit GV, Calabrese SK, Cunningham CO, Fiellin DA, Patel VV, Phillips KA, Tetrault JM, Shah M, Edelman EJ. A cross-sectional online survey of HIV pre-exposure prophylaxis adoption among primary care physicians. J Gen Intern Med 2017; 32 62–70.
| A cross-sectional online survey of HIV pre-exposure prophylaxis adoption among primary care physicians.Crossref | GoogleScholarGoogle Scholar |
[7] Karris MY, Beekmann SE, Mehta SR, Anderson CM, Polgreen PM. Are we prepped for or preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada. Clin Infect Dis 2014; 58 704–12.
| Are we prepped for or preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada.Crossref | GoogleScholarGoogle Scholar |
[8] Wood BR, McMahan VM, Naismith K, Stockton JB, Delaney LA, Stekler JD. Knowledge, practices, and barriers to HIV pre-exposure prophylaxis (PrEP) prescribing among Washington State medical providers. Sex Transm Dis 2018; 45 452–8.
| Knowledge, practices, and barriers to HIV pre-exposure prophylaxis (PrEP) prescribing among Washington State medical providers.Crossref | GoogleScholarGoogle Scholar |
[9] Seidman D, Carlson K, Weber S, Witt J, Kelly PJ. United States family planning providers’ knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey. Contraception 2016; 93 463–9.
| United States family planning providers’ knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey.Crossref | GoogleScholarGoogle Scholar |
[10] Smith DK, Mendoza MC, Stryker JE, Rose CE. PrEP awareness and attitudes in a national survey of primary care clinicians in the United States, 2009–2015. PLoS One 2016; 11 e0156592
| PrEP awareness and attitudes in a national survey of primary care clinicians in the United States, 2009–2015.Crossref | GoogleScholarGoogle Scholar |
[11] Silapaswan A, Krakower D, Mayer KH. Pre-exposure prophylaxis: a narrative review of provider behavior and interventions to increase PrEP implementation in primary care. J Gen Intern Med 2017; 32 192–8.
| Pre-exposure prophylaxis: a narrative review of provider behavior and interventions to increase PrEP implementation in primary care.Crossref | GoogleScholarGoogle Scholar |
[12] Castel AD, Feaster DJ, Tang W, Willis S, Jordan H, Villamizar K, Kharfen M, Kolber MA, Rodriguez A, Metsch LR. Understanding HIV care provider attitudes regarding intentions to prescribe PrEP. J Acquir Immune Defic Syndr 2015; 70 520–8.
| Understanding HIV care provider attitudes regarding intentions to prescribe PrEP.Crossref | GoogleScholarGoogle Scholar |
[13] Blumenthal J, Jain S, Krakower D, Sun X, Young J, Mayer K, Haubrich R, CCTG 598 Team. Knowledge is power! Increased provider knowledge scores regarding pre-exposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescribe PrEP. AIDS Behav 2015; 19 802–10.
| Knowledge is power! Increased provider knowledge scores regarding pre-exposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescribe PrEP.Crossref | GoogleScholarGoogle Scholar |
[14] Arora S, Thornton K, Murata G, Deming P, Kalishman S, Dion D, Parish B, Burke T, Pak W, Dunkelberg J, Kistin M, Brown J, Jenkusky S, Komaromy M, Qualls C. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med 2011; 364 2199–207.
| Outcomes of treatment for hepatitis C virus infection by primary care providers.Crossref | GoogleScholarGoogle Scholar |
[15] Wood BR, Unruh KT, Martinez-Paz N, Annese M, Ramers CB, Harrington RD, Dhanireddy S, Kimmerly L, Scott JD, Spach DH. Impact of a telehealth program that delivers remote consultation and longitudinal mentorship to community HIV providers. Open Forum Infect Dis 2016; 3 ofw123
| Impact of a telehealth program that delivers remote consultation and longitudinal mentorship to community HIV providers.Crossref | GoogleScholarGoogle Scholar |
[16] Centers for Disease Control and Prevention (CDC). Preexposure prophylaxis for the prevention of HIV in the United States – 2014 Clinical Practice Guidelines. Atlanta: CDC; 2014. Available online at: https://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf [verified 1 December 2017].
[17] Socolovsky C, Masi C, Hamlish T, Aduana G, Arora S, Bakris G, Johnson D. Evaluating the role of key learning theories in ECHO: a telehealth educational program for primary care providers. Prog Community Health Partnersh 2013; 7 361–8.
| Evaluating the role of key learning theories in ECHO: a telehealth educational program for primary care providers.Crossref | GoogleScholarGoogle Scholar |
[18] Hood JE, Buskin SE, Dombroski JC, Kern DA, Barash EA, Katz DA, Golden MR. Dramatic increase in preexposure prophylaxis use among MSM in Washington State. AIDS 2016; 30 515–9.
[19] Laufer FN, O’Connell DA, Feldman I, Zucker HA. Vital signs: increased Medicaid prescriptions for preexposure prophylaxis against HIV infection—New York, 2012–2015. MMWR Morb Mortal Wkly Rep 2015; 64 1296–301.
| Vital signs: increased Medicaid prescriptions for preexposure prophylaxis against HIV infection—New York, 2012–2015.Crossref | GoogleScholarGoogle Scholar |
